These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20574753)

  • 1. Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report.
    Dacci P; Riva N; Scarlato M; Andresen I; Schmidt D; Comi G; Fazio R
    Neurol Sci; 2010 Dec; 31(6):829-31. PubMed ID: 20574753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.
    Eftimov F; Vermeulen M; de Haan RJ; van den Berg LH; van Schaik IN
    J Peripher Nerv Syst; 2009 Jun; 14(2):93-100. PubMed ID: 19691531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy.
    Harbo T; Andersen H; Jakobsen J
    Neurology; 2010 Oct; 75(15):1377-80. PubMed ID: 20938030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
    Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M
    J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.
    Hachulla E; Benveniste O; Hamidou M; Mouthon L; Schleinitz N; Lozeron P; Léger JM; Vial C; Viala K
    Int J Neurosci; 2017 Jun; 127(6):516-523. PubMed ID: 27412148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
    Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
    Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
    Markvardsen LH; Christiansen I; Jakobsen J
    Transfusion; 2016 Oct; 56(10):2443-2448. PubMed ID: 27401495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal motor neuropathy: current therapies and novel strategies.
    Nobile-Orazio E; Gallia F
    Drugs; 2013 Apr; 73(5):397-406. PubMed ID: 23516024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous immunoglobulin for treatment of multifocal motor neuropathy.
    Katzberg HD; Rasutis V; Bril V
    Muscle Nerve; 2016 Nov; 54(5):856-863. PubMed ID: 26991654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.
    Harbo T; Andersen H; Hess A; Hansen K; Sindrup SH; Jakobsen J
    Eur J Neurol; 2009 May; 16(5):631-8. PubMed ID: 19236457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dose Subcutaneous Immunoglobulin in Patients With Multifocal Motor Neuropathy: A Nursing Perspective.
    Rasutis VM; Katzberg HD; Bril V
    J Infus Nurs; 2017; 40(5):305-312. PubMed ID: 28885479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons in fluctuation of muscle strength and function in patients with immune-mediated neuropathy treated with intravenous versus subcutaneous immunoglobulin.
    Christiansen I; Markvardsen LH; Jakobsen J
    Muscle Nerve; 2018 Apr; 57(4):610-614. PubMed ID: 28881389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between intravenous and subcutmaneous immunogobulin.
    Braine ME; Woodall A
    Br J Nurs; 2012 Apr 26-May 9; 21(8):S21-2, S24-7. PubMed ID: 22629593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction.
    Hadden RD; Marreno F
    Ther Adv Neurol Disord; 2015 Jan; 8(1):14-9. PubMed ID: 25584070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of Lewis-Sumner syndrome with subcutaneous immunoglobulin infusions.
    Bayas A; Gold R; Naumann M
    J Neurol Sci; 2013 Jan; 324(1-2):53-6. PubMed ID: 23095259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifocal motor neuropathy.
    Nobile-Orazio E
    J Neuroimmunol; 2001 Apr; 115(1-2):4-18. PubMed ID: 11282149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.
    Markvardsen LH; Sindrup SH; Christiansen I; Olsen NK; Jakobsen J; Andersen H;
    Eur J Neurol; 2017 Feb; 24(2):412-418. PubMed ID: 28000311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy.
    Gentile L; Russo M; Rodolico C; Arimatea I; Vita G; Toscano A; Mazzeo A
    Sci Rep; 2021 Apr; 11(1):9216. PubMed ID: 33911162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.